Comparative Effectiveness and Safety of Upadacitinib, Abrocitinib, and Dupilumab in Treatment-Resistant Prurigo Nodularis.


Demirbas A., Diremsizoglu E., Esen M., Ulutas Demirbas G.

Clinical and experimental dermatology, 2025 (SCI-Expanded, Scopus) identifier